Curium Announces the Submission of its Marketing Authorization Application for [18F]-DCFPyL to the European Medicines Agency
27 juin 2022 01h00 HE | Curium
Submission follows the completion of Phase III PYTHON clinical trial of [18F]-DCFPyL for recurrent prostate cancer in Europe in May 2022Phase III PYTHON clinical trial results to be presented at the...
Middle East Liquid Biopsy Market Research Report 2022: Amalgamation of Artificial Intelligence (AI) with Non-Invasive Liquid Biopsy Presents Opportunities
22 juin 2022 05h43 HE | Research and Markets
Dublin, June 22, 2022 (GLOBE NEWSWIRE) -- The "Middle East Liquid Biopsy Market - Country Analysis: Focus on Product, Technology, Indication, Sample, Workflow, Circulating Biomarker, Usage, and...
MetasTx LLC Raises Funds, Engages Manufacturing Partner, And Advances Phase One Development
07 juin 2022 07h22 HE | MetasTx LLC
BASKING RIDGE, N.J., June 07, 2022 (GLOBE NEWSWIRE) -- MetasTx LLC is driven to create novel therapeutics to treat and prevent metastasis of cancers. Harvey Homan, CEO and Co-Founder has...
Arvinas to Present at Goldman Sachs 43rd Annual Global Healthcare Conference
02 juin 2022 16h00 HE | Arvinas Inc.
NEW HAVEN, Conn., June 02, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Arvinas Launches Global Early Career Researcher Award and Announces Call for Nominations
01 juin 2022 08h00 HE | Arvinas Inc.
-- In honor of 20 years of targeted protein degradation, Arvinas announces $25,000 prize to recognize the efforts of an up-and-coming researcher in the field of targeted protein degradation – --...
Global Radiation Oncology Market Estimated to Generate $10,679.7 Million and Grow at 7.4% CAGR During the 2020-2027 Timeframe [248-Pages] | Research Dive
18 mai 2022 09h05 HE | Research Dive
New York, USA, May 18, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global radiation oncology market is estimated to generate a revenue of $10,679.7 million by...
Curium Confirms No Supply Challenges of 177Lu-PSMA-I&T for ECLIPSE Trial
12 mai 2022 01h05 HE | Curium
ST. LOUIS, May 12, 2022 (GLOBE NEWSWIRE) -- Curium confirmed today no supply challenges of 177Lu-PSMA-I&T for the Phase 3 ECLIPSE clinical trial (NCT05204927), evaluating Lutetium...
Global Radioligand Therapy Markets, 2020-2021 & 2022-2031: Expanding Radiopharmaceutical Coverage & Radioligand Therapy Demand Inclined by Rising Prevalence of Cancer
11 mai 2022 04h03 HE | Research and Markets
Dublin, May 11, 2022 (GLOBE NEWSWIRE) -- The "Radioligand Therapy Market - A Global and Regional Analysis: Focus on Indication, Product, Biomarker, and Region - Analysis and Forecast, 2021-2031"...
Outlook on the Oncology Sterile Injectables Global Market to 2028 - Faster Drug Approvals from Various Regulatory Bodies are Driving Growth
06 mai 2022 04h23 HE | Research and Markets
Dublin, May 06, 2022 (GLOBE NEWSWIRE) -- The "Oncology Sterile Injectables Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to...
Arvinas Reports First Quarter 2022 Financial Results and Provides Corporate Update
05 mai 2022 07h00 HE | Arvinas Inc.
NEW HAVEN, Conn., May 05, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...